BIOMATERIALS
Scope & Guideline
Connecting Research, Application, and Innovation in Biomaterials
Introduction
Aims and Scopes
- Biomaterials for Regenerative Medicine:
Research in this area focuses on the development and application of biomaterials that can support tissue regeneration and repair, including scaffolds, hydrogels, and 3D printed constructs designed to enhance healing in various tissues. - Nanomedicine and Drug Delivery Systems:
This scope encompasses the design and application of nanomaterials for targeted and controlled drug delivery, enhancing therapeutic efficacy while minimizing side effects, particularly in cancer treatment and chronic diseases. - Bioengineering and Tissue Engineering:
The journal highlights studies that integrate engineering principles with biological systems, focusing on the creation of functional tissues and organs, including organ-on-a-chip technologies and bioprinting. - Immunomodulation and Therapeutic Applications:
Research that explores how biomaterials can modulate immune responses to improve therapeutic outcomes, particularly in cancer immunotherapy and regenerative medicine. - Biocompatibility and Safety Evaluation:
The journal publishes studies assessing the biocompatibility, toxicity, and long-term effects of biomaterials in biological systems, which are critical for their clinical translation. - Smart Biomaterials and Responsive Systems:
This area includes the development of materials that respond to environmental stimuli (e.g., pH, temperature, light) for dynamic therapeutic applications.
Trending and Emerging
- Advanced Nanotherapeutics:
There is a growing emphasis on the development of nanomaterials that can deliver drugs or therapeutic agents with high precision, including nanocarriers that enhance the efficacy of immunotherapies and chemotherapies. - 3D Bioprinting and Organ-on-a-Chip Technologies:
The trend towards creating complex tissue structures using 3D bioprinting techniques is increasing, along with the development of organ-on-a-chip systems that mimic human organ functions for drug testing and disease modeling. - Biomaterials for Cancer Immunotherapy:
Research is trending towards the use of biomaterials as platforms for cancer immunotherapy, focusing on how these materials can enhance immune responses and target tumor microenvironments. - Smart and Responsive Biomaterials:
There is an emerging interest in biomaterials that respond to specific stimuli (light, temperature, pH), allowing for on-demand drug release and dynamic therapeutic applications. - Microenvironment Engineering:
An increasing number of studies are focusing on how the engineered microenvironment can influence cell behavior, particularly in the context of stem cell therapy and tissue regeneration. - Sustainable and Green Biomaterials:
There is a rising trend towards developing environmentally friendly biomaterials derived from natural sources, emphasizing sustainability and biocompatibility.
Declining or Waning
- Traditional Biomaterials without Functionalization:
There has been a noticeable decrease in studies focusing solely on traditional biomaterials (such as simple hydrogels or polymers) without advanced functionalization or modification to enhance their properties or applications. - In vitro Studies without Translation to In Vivo Models:
Research that remains solely within in vitro studies without progressing to in vivo validation is declining, as there is a greater emphasis on translational research that can lead to practical applications in clinical settings. - Non-targeted Drug Delivery Approaches:
As precision medicine becomes more prominent, there is a waning interest in non-targeted drug delivery systems, with more focus shifting towards targeted and personalized therapies. - Static Biomaterial Studies:
Static studies that do not incorporate dynamic or responsive elements in biomaterials are becoming less frequent, as there is a growing interest in materials that can adapt to physiological conditions.
Similar Journals
MACROMOLECULAR BIOSCIENCE
Advancing the Frontiers of Macromolecular InnovationMACROMOLECULAR BIOSCIENCE, published by WILEY-V C H VERLAG GMBH, is a leading journal in the fields of bioengineering, biomaterials, biotechnology, materials chemistry, and polymers and plastics. With a convergence of scientific inquiry since its inception in 2001, the journal has established itself as a vital resource for researchers and professionals exploring the interface of molecular sciences and biosystems. It boasts impressive Scopus rankings, including Q1 status in multiple categories, reflecting its significant contribution to advancing knowledge and innovation in the polymer and biomaterials domains. While the journal does not currently offer open access options, its rigorous peer-review process ensures the publication of high-quality research that fuels academic discourse. Positioned in Weinheim, Germany, MACROMOLECULAR BIOSCIENCE aims to bridge theoretical understanding with practical applications, making it an essential reference for students, academics, and industry practitioners dedicated to the evolving landscape of macromolecular bioscience.
JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
Innovating Biocompatibility for a Sustainable FutureJOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS, published by SAGE PUBLICATIONS LTD, serves as a pivotal platform for disseminating innovative research in the fields of bioengineering, biomaterials, materials chemistry, and polymers. With an ISSN of 0883-9115 and an E-ISSN of 1530-8030, this journal is committed to the advancement of knowledge relating to the interaction of polymers within biological systems and their compatibility in various applications. Operating since 1986, the journal has garnered a respectable presence, ranked in the Q3 quartile across multiple categories in 2023, indicating its relevance and contribution to these dynamic fields. Although not open access, the journal ensures that high-quality research is accessible to subscribers and institutions, reinforcing its importance for researchers, professionals, and students aiming to stay abreast of advancements in polymer science and biocompatibility. By fostering interdisciplinary communication and collaboration, the JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS continues to play a crucial role in shaping the future of material applications in health, technology, and industry.
VIEW
Fostering Collaboration for a Healthier Tomorrow.VIEW is a prestigious journal published by WILEY that focuses on the rapidly evolving fields of Biomaterials and Biomedical Engineering. Since its inception in 2020, VIEW has established itself as an open-access platform dedicated to disseminating high-quality research and innovation within these disciplines. With an impressive impact factor that places it in the Q1 category of both Biomaterials and Biomedical Engineering, VIEW ranks among the top journals in its field, boasting a 91st percentile ranking in Biomedical Engineering and an 85th percentile ranking in Materials Science. Researchers, professionals, and students are encouraged to utilize this invaluable resource, as it provides a comprehensive view of current advancements and future trends in biomaterial science and engineering. Positioned in the United Kingdom, VIEW operates as a vital scholarly communication link, fostering collaboration and knowledge sharing within an ever-growing global community.
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
Unleashing the Potential of Materials in Medical ApplicationsJOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE is a leading peer-reviewed journal published by Springer, dedicated to advancing the field of biomedical materials science. With an ISSN of 0957-4530 and E-ISSN 1573-4838, this Open Access journal has been committed to providing researchers and professionals with freely accessible, high-quality research since 2021. It features an extensive scope spanning bioengineering, biomaterials, biomedical engineering, and biophysics, reflecting its significant impact within these interdisciplinary domains. Recognized within the Q2 category of the 2023 rankings in multiple fields, the journal proudly positions itself as a crucial resource for innovative materials that contribute to advancements in medical applications. With impressive Scopus rankings, including 26th in Biophysics and 40th in Materials Science for Biomaterials, researchers, students, and industry professionals alike can rely on this publication for cutting-edge insights that drive the future of medical materials and technologies. Based in Dordrecht, Netherlands, the journal provides a vibrant platform for sharing groundbreaking discoveries and fostering collaborative research among a global audience.
International Journal of Nanomedicine
Exploring the frontiers of nanotechnology in medicine.International Journal of Nanomedicine, published by DOVE MEDICAL PRESS LTD, is a leading open access journal dedicated to advancing the field of nanomedicine and its applications in healthcare. Since its establishment in 2006, the journal has grown significantly, now encompassing a wide array of topics including bioengineering, biomaterials, biophysics, drug discovery, and pharmaceutical sciences, and is recognized in Q1 quartiles across major categories like *Nanoscience and Nanotechnology* and *Organic Chemistry*. The journal boasts an impressive standing within the Scopus rankings, with high percentiles across various related fields, making it an invaluable resource for researchers, professionals, and students seeking to stay informed on the latest innovations and developments in nanomedicine. With its commitment to fostering an accessible and collaborative academic environment, the International Journal of Nanomedicine serves as a vital platform for disseminating transformative research that impacts scientific practice and healthcare outcomes globally.
Advanced NanoBiomed Research
Innovating at the Intersection of Science and MedicineAdvanced NanoBiomed Research is a pioneering open-access journal committed to advancing the interdisciplinary field of nanobiotechnology, published by WILEY-V C H VERLAG GMBH. Since its inception in 2021, this journal has provided a platform for innovative research that bridges the gap between engineering, medicine, and materials science. With impressive rankings in Scopus, positioning it within the top quartiles of various categories, Advanced NanoBiomed Research aims to disseminate high-quality research that contributes to the understanding and application of nanomaterials in biomedical contexts. As it encompasses a wide scope—from applied microbiology to biomaterials—it serves as an essential resource for researchers, professionals, and students eager to explore the cutting-edge developments in the field. The journal promotes a collaborative environment where emerging ideas can flourish, ensuring that vital advancements in nanobiomedicine can be shared and built upon within the scientific community.
Biomaterials Science
Pioneering advancements in biomaterials for a healthier world.Biomaterials Science is a premier journal published by the Royal Society of Chemistry that serves as a leading platform for researchers and professionals in the fields of Biomedical Engineering and Materials Science. With an impressive impact factor bolstered by its Q1 quartile ranking in both disciplines, this journal has positioned itself at the forefront of cutting-edge research, showcasing innovative materials and applications that drive advancements in healthcare and technology. Since its inception in 2013, Biomaterials Science has been committed to disseminating high-quality, peer-reviewed articles that promote scientific knowledge and collaboration among academia and industry. With a global readership and a focus on open access, researchers are encouraged to share their findings to facilitate the development of transformative biomaterials and their applications. Join a vibrant community of scholars as we explore the future of biomaterials through this esteemed publication, enhancing both scientific inquiry and practical application.
ACS Biomaterials Science & Engineering
Connecting Research and Application for a Healthier TomorrowACS Biomaterials Science & Engineering, published by the American Chemical Society, serves as a premier platform for the latest advancements and research in the fields of biomaterials and biomedical engineering. With an impressive impact factor and a strong reputation reflected in its ranking—Q2 in Biomaterials and Q1 in Biomedical Engineering—the journal attracts a diverse and engaged readership. Since its inception in 2015, it has aimed to foster innovation by publishing high-quality research articles, reviews, and perspectives on the synthesis, characterization, and application of biomaterials. Researchers and professionals benefit from the journal's rigorous peer-review process and its focus on translational science, making it essential for those looking to stay at the forefront of biomaterials research. Located in Washington, DC, USA, the journal plays a pivotal role in connecting academic and industrial sectors, ultimately driving advancements that impact biomedicine and related fields.
Advanced Therapeutics
Advancing the frontiers of medical innovation.Advanced Therapeutics, published by WILEY in the United Kingdom, stands at the forefront of medical and pharmaceutical research, offering invaluable insights from 2018 to 2024. This distinguished journal, with an E-ISSN of 2366-3987, is recognized for its exceptional academic rigor, boasting an impressive array of Q1 categorizations in essential fields such as Biochemistry (medical), Pharmaceutical Science, and Pharmacology. With its strategic focus on interdisciplinary studies and cutting-edge therapeutic developments, Advanced Therapeutics serves as a vital resource for researchers, professionals, and students keen on advancing their knowledge and contributing to the evolving landscape of medicine and genetics. The journal's high Scopus rankings further affirm its impact, with significant placements in multiple categories underscoring the quality of published research. Although the journal operates under a subscription model, its accessibility to high-impact findings ensures that it remains a pivotal platform for innovative discourse in therapeutics.
Biomaterials Advances
Elevating Biomaterials Science for a Healthier TomorrowBiomaterials Advances is a premier journal published by Elsevier, dedicated to the rapidly evolving field of biomaterials. Established in the United Kingdom, this open-access journal aims to disseminate high-quality, peer-reviewed research that explores innovative biomaterial designs and their applications in bioengineering and biomedical engineering. With an impressive 2023 impact factor reflected in its Q1 rankings across multiple categories—including Bioengineering, Biomaterials, and Biomedical Engineering—Biomaterials Advances stands out as a critical platform for scholars and practitioners faced with advancing technologies and methodologies in the realm of materials science. Covering a broad range of topics, from biocompatibility to tissue engineering, this journal provides an inclusive forum for researchers seeking to contribute to the field. Its Scopus rankings further affirm its position as a leading resource, with notable standings in Biomedical Engineering (Rank #13), Biomaterials (Rank #8), and Bioengineering (Rank #11), all within the top percentiles. Researchers and students alike are encouraged to contribute and engage with the latest findings and innovations in biomaterials through this valuable publication.